axitinib plus pembrolizumab in advanced rcc
Published 4 years ago • 1K plays • Length 2:31Download video MP4
Download video MP3
Similar videos
-
5:10
real-world treatment outcomes of 1l axitinib pembrolizumab in patients with advanced rcc in the us
-
3:30
promising results for axitinib and pembrolizumab in advanced renal cell cancer
-
1:17
dr. vaishampayan on axitinib plus pembrolizumab in advanced rcc
-
1:00
pembrolizumab/axitinib and avelumab/axitinib combo for rcc
-
2:18
pembrolizumab monotherapy and pembro-axitinib for rcc
-
2:27
combining avelumab and axitinib in advanced renal cell carcinoma (rcc)
-
1:40
dr. powles on fda approval of pembrolizumab plus axitinib in advanced rcc
-
3:28
dr rini on a biomarker analysis for pembrolizumab/axitinib in advanced rcc
-
0:49
clear: lenvatinib and pembrolizumab in advanced renal cell carcinoma
-
0:57
avelumab and axitinib for the treatment of advanced rcc
-
1:06
exciting potential of pembrolizumab combined with axitinib for kidney cancer
-
2:06
updated analysis of keynote-426: pembro plus axitinib vs sunitinib in mrcc
-
4:47
keynote-426 - pembrolizumab plus axitinib versus sunitinib for mrcc
-
2:23
overview of a phase iii trial of pembrolizumab plus axitinib in rcc
-
1:29
phase i/ii study of nivolumab and axitinib for advanced rcc
-
1:34
dr. rini on pembrolizumab plus axitinib in rcc
-
1:19
dr. rini on the efficacy of axitinib and pembrolizumab in rcc
-
1:44
assessing lenvatinib with pembrolizumab in advanced renal cell carcinoma
-
1:56
dr. cost on pembrolizumab plus axitinib in patients with rcc